阳光诺和：ABA001注射液临床试验申请获得受理

Core Viewpoint - Sunshine Nuohuo (688621) has received approval from the National Medical Products Administration for the clinical trial application of its research project ABA001 injection, which is intended for the treatment of hypertension [1]. Company Summary - Sunshine Nuohuo and its wholly-owned subsidiary Beijing Arna Technology Co., Ltd. have been granted a "Notice of Acceptance" for the clinical trial application of ABA001 injection [1]. - The proposed indication for ABA001 injection is hypertension [1].